| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 21 | +71.43% | -1.58% | +0.53% | -2.11% | -3.35% | — |
| 14d | 21 | +66.67% | -1.41% | +0.99% | -2.40% | -4.45% | — |
| 30d | 21 | +71.43% | -2.20% | +2.21% | -4.41% | -8.06% | — |
| 60d | 21 | +61.90% | -1.61% | +4.10% | -5.70% | -8.51% | — |
| 90d | 21 | +61.90% | +0.41% | +2.65% | -2.24% | -10.90% | — |
| 180d | 21 | +80.95% | -30.93% | +7.48% | -38.41% | -45.30% | — |
| 1y | 21 | +80.95% | -29.57% | +15.82% | -45.39% | -74.54% | — |
| 2y | 21(2 pending) | +100.00% | -65.78% | +32.80% | -98.58% | -99.40% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 850,000 | — | — | 850,000 | Feb 12, 2025 | Feb 14, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 74,773 | $0.45 | $33.9K | 0 | Jan 24, 2025 | Jan 27, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 74,773 | — | — | 74,773 | Jan 23, 2025 | Jan 27, 2025 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 230,645 | $0.55 | $126.9K | 0 | Oct 7, 2024 | Oct 8, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 230,645 | — | — | 230,645 | Oct 4, 2024 | Oct 8, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 52,500 | $0.88 | $46.3K | 0 | Mar 11, 2024 | Mar 11, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 523,414 | — | — | 523,414 | Feb 13, 2024 | Feb 16, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 27,721 | $1.01 | $28.0K | 52,500 | Feb 12, 2024 | Feb 12, 2024 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE10b5-1 10b5-1 plan | 230,645 | $0.73 | $168.4K | 80,221 | Nov 1, 2023 | Nov 3, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 230,645 | — | — | 310,866 | Oct 31, 2023 | Nov 2, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 2,641 | $1.89 | $5.0K | 80,221 | Jun 30, 2023 | Jul 5, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 5,417 | $1.93 | $10.5K | 82,862 | Jun 23, 2023 | Jun 26, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 5,417 | $2.22 | $12.0K | 88,279 | Jun 15, 2023 | Jun 16, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 52,500 | $0.84 | $44.1K | 93,696 | Mar 10, 2023 | Mar 13, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 27,721 | $0.93 | $25.8K | 146,196 | Feb 13, 2023 | Feb 15, 2023 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 1,350,000 | — | — | 1,350,000 | Nov 7, 2022 | Nov 9, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 10,834 | — | — | 173,917 | Aug 17, 2022 | Aug 19, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 2,641 | — | — | 184,751 | Jun 30, 2022 | Jul 1, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 5,416 | — | — | 187,392 | Jun 24, 2022 | Jun 27, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 5,416 | — | — | 192,808 | Jun 16, 2022 | Jun 17, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 105,000 | — | — | 198,224 | Mar 1, 2022 | Mar 1, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 27,721 | — | — | 93,224 | Feb 11, 2022 | Feb 14, 2022 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 10,832 | $5.10 | $55.2K | 120,945 | Aug 17, 2021 | Aug 19, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 2,641 | $6.64 | $17.5K | 131,777 | Jun 30, 2021 | Jul 1, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 5,417 | $7.01 | $38.0K | 134,418 | Jun 24, 2021 | Jun 25, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 16,250 | — | — | 139,835 | Jun 23, 2021 | Jun 25, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 16,250 | — | — | 129,002 | Jun 15, 2021 | Jun 17, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 5,417 | $7.84 | $42.5K | 123,585 | Jun 15, 2021 | Jun 17, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 83,163 | — | — | 112,752 | Mar 24, 2021 | Mar 25, 2021 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE Chief Financial Officer | 10,834 | $7.08 | $76.7K | 29,589 | Sep 21, 2020 | Sep 22, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 16,250 | — | — | 40,423 | Aug 17, 2020 | Aug 18, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | PURCHASEGRANT Stock grant | 16,250 | — | — | 24,173 | Aug 14, 2020 | Aug 18, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE See Remarks | 916 | $9.32 | $8.5K | 7,923 | Jun 30, 2020 | Jul 1, 2020 ↗ | View → |
| XFOR X4 PHARMACEUTICALS, INC | SALE See Remarks | 1,725 | $9.04 | $15.6K | 8,839 | Jun 30, 2020 | Jul 1, 2020 ↗ | View → |